Opioid receptors and preconditioning of the heart

Joana Saraiva1, Sílvia Marta Oliveira, Amândio Rocha-Sousa

  • 1Serviço de Fisiologia da Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

Insights

Opioid receptors, known for pain relief, also regulate the cardiovascular system. This review explores their direct effects on heart tissue and blood vessels, highlighting cardioprotective actions.

Area of Science:

  • Cardiovascular Physiology
  • Neuropharmacology
  • Cardiac Medicine

Background:

  • Opioid receptors are primarily known for their role in analgesia within the central nervous system.
  • Emerging evidence suggests opioids and their receptors significantly influence cardiovascular regulation.
  • These cardiovascular effects may involve peripheral opioid receptors or direct actions on cardiac and vascular tissues.

Purpose of the Study:

  • To review the multifaceted roles of opioid receptor stimulation in the cardiovascular system.
  • To specifically examine the impact of opioid receptor activation on cardiac tissue.
  • To investigate how opioid receptor stimulation mimics the cardioprotective effects of ischemic preconditioning.

Main Methods:

  • Literature review of recent studies on opioid receptors and cardiovascular function.
  • Analysis of research investigating opioid effects on cardiac tissue.
  • Examination of studies comparing opioid receptor stimulation to ischemic preconditioning.

Main Results:

  • Opioid receptor stimulation influences cardiovascular regulation beyond central nervous system effects.
  • Direct effects of opioid receptors on cardiac tissue and peripheral vasculature are evident.
  • Opioid receptor activation demonstrates cardioprotective properties, similar to ischemic preconditioning.

Conclusions:

  • Opioid receptors play a crucial, yet underappreciated, role in cardiovascular homeostasis.
  • Direct cardiac effects of opioid receptor stimulation offer potential therapeutic strategies.
  • Understanding these mechanisms could lead to novel cardioprotective interventions.

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Spare Receptors01:30

Spare Receptors

Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...